Accounts Receivable, after Allowance for Credit Loss, Current of BioCorRx Inc. from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
BioCorRx Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • BioCorRx Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $194,442.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

BioCorRx Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $194,442 +$194,442 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $51,242 +$51,242 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $111,966 +$111,966 31 Mar 2025 10-Q 15 May 2025 2024 Q1
Q4 2024 $0 -$740 -100% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $0 -$12,215 -100% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $0 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $0 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $740 -$34,638 -98% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $12,215 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q4 2022 $35,378 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2012 $925,813 -$397,044 -75% 31 Dec 2012 10-K 15 Apr 2013 2012 FY
Q3 2012 $406,179 +$122,965 +23% 30 Sep 2012 10-Q 19 Nov 2012 2012 Q3
Q2 2012 $406,836 -$53,392 -15% 30 Jun 2012 10-Q/A 24 Sep 2012 2012 Q2
Q4 2011 $528,769 31 Dec 2011 10-K 15 Apr 2013 2012 FY
Q3 2011 $529,144 30 Sep 2011 10-Q 19 Nov 2012 2012 Q3
Q2 2011 $353,444 30 Jun 2011 10-Q/A 24 Sep 2012 2012 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.